search
Back to results

The Effects of Periodontal Therapy on Glycemic Control in Diabetic Patients

Primary Purpose

Chronic Periodontitis, Generalized

Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
amoxicillin 500mg and metronidazole 400mg
Sponsored by
Taibah University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Periodontitis, Generalized

Eligibility Criteria

40 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Diagnosis of diabetes type 2 for more than five years Type 2 diabetes with HbA1c level from 7% to 9% at the last medical evaluation Diagnosis with chronic periodontitis

Exclusion Criteria:

Pregnancy

  • Alcoholism and smoking
  • Presence of any systemic disorders other than hypertension and diabetes
  • Diabetic major complications

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    test group

    control group

    Arm Description

    Metronidazole 400mg,three times daily for two weeks Amoxicillin 500mg,three times daily for two weeks.

    no intervention during study period

    Outcomes

    Primary Outcome Measures

    glycosylated haemoglobin (HbA1c)
    Blood was taken from a peripheral vein to monitor HbA1c using high-performance liquid chromatography

    Secondary Outcome Measures

    Full Information

    First Posted
    December 19, 2018
    Last Updated
    October 17, 2019
    Sponsor
    Taibah University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03783845
    Brief Title
    The Effects of Periodontal Therapy on Glycemic Control in Diabetic Patients
    Official Title
    The Effects of Non -Surgical Periodontal Therapy on Glycemic Control and Periodontal Health in Diabetic Patients With Periodontitis (Randomized Controlled Clinical Trial)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2019
    Overall Recruitment Status
    Completed
    Study Start Date
    June 1, 2015 (Actual)
    Primary Completion Date
    March 1, 2016 (Actual)
    Study Completion Date
    March 30, 2016 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Taibah University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Is the non-surgical periodontal therapy can improve glycemic control in type 2 diabetic patients with chronic periodontitis?
    Detailed Description
    The aim of the present study was to monitor the clinical outcomes and the metabolic response of non-surgical periodontal therapy in patients with chronic periodontitis and uncontrolled type 2 diabetes. Regarding clinical and metabolic parameters at baseline, no differences were displayed between two groups. However, at 3-months follow-up period the patients within a test group were demonstrated better clinical outcomes than patients in a control group

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Chronic Periodontitis, Generalized

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 4
    Interventional Study Model
    Single Group Assignment
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    44 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    test group
    Arm Type
    Experimental
    Arm Description
    Metronidazole 400mg,three times daily for two weeks Amoxicillin 500mg,three times daily for two weeks.
    Arm Title
    control group
    Arm Type
    No Intervention
    Arm Description
    no intervention during study period
    Intervention Type
    Combination Product
    Intervention Name(s)
    amoxicillin 500mg and metronidazole 400mg
    Other Intervention Name(s)
    Amoxil and Flagyl
    Intervention Description
    metronidazole 400mg and amoxicillin 500mg three times daily for two weeks
    Primary Outcome Measure Information:
    Title
    glycosylated haemoglobin (HbA1c)
    Description
    Blood was taken from a peripheral vein to monitor HbA1c using high-performance liquid chromatography
    Time Frame
    3 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    40 Years
    Maximum Age & Unit of Time
    70 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Diagnosis of diabetes type 2 for more than five years Type 2 diabetes with HbA1c level from 7% to 9% at the last medical evaluation Diagnosis with chronic periodontitis Exclusion Criteria: Pregnancy Alcoholism and smoking Presence of any systemic disorders other than hypertension and diabetes Diabetic major complications

    12. IPD Sharing Statement

    Learn more about this trial

    The Effects of Periodontal Therapy on Glycemic Control in Diabetic Patients

    We'll reach out to this number within 24 hrs